Monday delivered a solid day for U.S. markets, with all three major indexes closing in positive territory. But the real action was in individual stocks reacting to everything from geopolitical upheaval to pharmaceutical breakthroughs and AI innovations.

The big story over the weekend was Venezuela. A U.S. military strike led to the ousting of President Nicolás Maduro, and suddenly everyone's talking about American oil companies getting back into Venezuela's energy sector. That set the stage for some interesting moves in energy stocks.

Chevron Corp. (NYSE:CVX)

Chevron Corp. (CVX) had the kind of day that reminds you why geopolitics matters for oil stocks. Shares surged 5.1% to close at $163.85, hitting an intraday high of $165.75. The stock's 52-week range sits between $132.04 and $168.96.

The Venezuela situation is driving this rally. With political change comes opportunity, and investors are betting Chevron stands to benefit significantly from renewed access to Venezuelan oil. The company already has history in the region, which gives it operational leverage that competitors might not have.

NVIDIA Corp. (NASDAQ:NVDA)

NVIDIA Corp. (NVDA) dipped slightly, down 0.39% to close at $188.12. The stock traded between an intraday high of $193.63 and a low of $186.15, with its 52-week range spanning $86.63 to $212.19.

But the modest decline doesn't tell the whole story. At CES 2026, NVIDIA unveiled Alpamayo AI, which represents a meaningful shift in autonomous vehicle technology. The new system uses vision language action models that bring human-like reasoning to vehicles. Think of it as teaching cars to understand context the way people do, not just follow programmed responses.

Novo Nordisk A/S (NYSE:NVO)

Novo Nordisk A/S (NVO) shares jumped 5.19% to $55.11, reaching an intraday high of $55.42 and a low of $53.36. Its 52-week range stretches from $43.08 to $93.80.

The company's Wegovy weight-loss pill is now available in U.S. pharmacies, and the clinical data looks compelling. Patients achieved an average weight loss of 17% when combining the pill with diet and exercise, compared to just 3% for placebo. That's the kind of efficacy that could capture serious market share, especially with Novo Nordisk's competitive pricing strategy aimed at making the treatment accessible.

Zeta Global Holdings Corp. (NYSE:ZETA)

Zeta Global Holdings Corp. (ZETA) had an impressive run, climbing 8.84% to close at $21.67. The stock hit an intraday high of $21.88 and a low of $20.29, with a 52-week range of $10.69 to $26.60. Then it popped another 10.56% to $23.96 in after-hours trading.

Here's the interesting part: there weren't any major headlines driving this move. The rally appears fueled by speculation and growing investor enthusiasm for the company's AI-powered marketing solutions. In a market obsessed with artificial intelligence applications, Zeta Global's technology is catching attention.

Exxon Mobil Corp. (NYSE:XOM)

Exxon Mobil Corp. (XOM) gained 2.21% to close at $125.36, with an intraday high of $125.93 and a low of $122.39. The stock's 52-week range runs from $97.80 to $125.93.

Like Chevron, Exxon Mobil is benefiting from the Venezuela developments. While Chevron might have operational advantages from existing relationships, Exxon's opportunity lies in legal recovery and strategic positioning. The company has long-standing claims in Venezuela that could suddenly become relevant again.

According to market data, Chevron stock scores in the 81st percentile for value when ranked against other players in the oil sector, including Exxon Mobil. That suggests investors see solid fundamentals backing up the recent price action.

The broader takeaway from Monday's trading? Sometimes the biggest moves come from unexpected places. A weekend military action in South America creates winners in Texas boardrooms. A pill launch validates years of pharmaceutical research. And an AI demonstration at a tech conference hints at the future of transportation. That's markets for you.